Read + Share
Takegawa N, Tsurutani J, Kawakami H, Yonesaka K, et al. [fam-] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression
level rather than on HER2 amplification. Int J Cancer 2019;145:3414-3424.
PMID: 31087550
|
 |
|
Takegawa N, Tsurutani J, Kawakami H, Yonesaka K, et al. [fam-] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression
level rather than on HER2 amplification. Int J Cancer 2019;145:3414-3424.
PMID: 31087550
|
|
|
|